This legislation would restore funding for the Congressionally Directed Medical Research Program (CDMRP) which was cut by 57% in the Full-Year Continuing Appropriations and Extensions Act, 2025. The CDMRP, administered by the Department of Defense, plays a vital role in advancing groundbreaking, peer-reviewed medical research that addresses critical gaps in our understanding and treatment of diseases like pancreatic cancer, breast cancer, ALS, multiple sclerosis, and many others.